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B cell-activating Factor regulates 
Different aspects of B cell 
Functionality and is Produced by  
a subset of splenic B cells in  
Teleost Fish
Carolina Tafalla*, Lucia González, Rosario Castro and Aitor G. Granja*
Laboratory of Fish Immunology and Pathology, Centro de Investigación en Sanidad Animal (CISA-INIA), Madrid, Spain
In mammals, B cell functionality is greatly influenced by cytokines released by innate 
cells, such as macrophages or dendritic cells, upon the early recognition of common 
pathogen patterns through invariant receptors. B  cell-activating factor (BAFF) is one 
of these innate B cell-helper signals and plays a key role in the survival and differenti-
ation of B cells. Although, evolutionarily, teleost fish constitute the first animal group in 
which adaptive immunity based on Ig receptors is present, fish still rely greatly on innate 
responses. In this context, we hypothesized that BAFF would play a key role in the control 
of B cell responses in fish. Supporting this, our results show that teleost BAFF recapit-
ulates mammalian BAFF stimulating actions on B cells, upregulating the expression of 
membrane MHC II, improving the survival of fish naïve B cells and antibody-secreting 
cells, and increasing the secretion of IgM. Surprisingly, we also demonstrate that BAFF 
is not only produced in fish by myeloid cells but is also produced by a subset of splenic 
B cells. Thus, if this B cell-produced BAFF proves to be actively regulating this same 
B cell subset, our findings point to an ancient mechanism to control B cell differentiation 
and survival in lower vertebrates, which has been silenced in mammals in physiological 
conditions, but reemerges under pathological conditions, such as B cell lymphomas and 
autoimmune diseases.
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inTrODUcTiOn
In mammals, conventional B cells, also designated as follicular B cells or B2 cells, produce high affinity 
antibodies in response to specific epitopes through a somatically recombined B cell receptor (BCR) 
and, to fulfill this, they require the cooperation of T helper cells in germinal centers (GCs) within 
the lymphoid follicles. These T-dependent responses are quite effective, but temporally delayed, so 
T-independent (TI) B cell responses are also mounted immediately after pathogen recognition, to 
produce low-affinity poly specific antibodies, which offer fast protection, especially at the mucosal 
interfaces. Innate B cells such as B1 cells or marginal zone (MZ) B cells are mostly responsible for 
these TI responses (1, 2). Exemplifying further the crosstalk that exists between the adaptive and the 
innate immune system, B cells (both B2 and innate B cells) receive additional stimulatory signals 
from other cells of the innate immune system such as dendritic cells (DCs), macrophages, or granu-
locytes. These innate cells, upon sensing of conserved pathogen features through invariant pattern 
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recognition receptors (PRRs), release B  cell-stimulating factors 
(3, 4) that elicit extrafollicular TI responses (5) or complement 
the activity of T helper cells in GCs (6).
B  cell-activating factor (BAFF) of the tumor necrosis factor 
(TNF) family (also known as BlyS, TALL-1, THANK, zTNF4, 
and TNFSF13B) and a proliferation-inducing ligand (APRIL), 
members of the TNF family, are two of the most important factors 
among these innate B cell-stimulating cytokines (7). Both of them 
are type II transmembrane proteins, which become soluble ligands 
after cleavage at the cell surface by a furin-like protease, with both 
the membrane-bound and soluble forms being biologically active 
(8). Concerning the receptors through which they signal, both 
BAFF and APRIL bind to B cell maturation antigen [(BCMA), 
also known as TNFRSF17] and transmembrane activator and 
calcium modulator and cyclophilin ligand interactor (TACI, also 
known as TNFRSF13B), whereas BAFF also binds to BAFF recep-
tor (BAFF-R, also known as BR3 or TNFRSF13C) (7). All three 
receptors are preferentially expressed in B cells (9, 10).
In mammals, BAFF is not a stimulator of B cell proliferation on 
its own, but acts as a potent co-stimulator when combined with 
BCR engagement (11). On the other hand, BAFF is a strong pro-
moter of B cell survival (12), mainly sustained through BAFF-R 
signaling (13). For this, BAFF-mediated NF-κB activation has 
been linked to increased expression of antiapoptotic proteins 
[reviewed in Ref. (14)]. On the other hand, TACI expression is 
highly inducible and has been shown to be particularly highly 
expressed in innate B1 cells (13) and consequently TACI−/− ani-
mals are unable to mount normal TI immune responses (15), as 
the activation and survival of plasmablasts derived from innate 
B cells is compromised (16). Regarding BCMA, BAFF signaling 
through this receptor has been proven to be essential for the 
survival of long-lived plasma cells (17). BCMA can also promote 
the antigen-presenting function of B  cells through upregula-
tion of MHC II and co-stimulatory molecules (18), although 
BAFF-mediated upregulation of MHC class II expression is also 
achieved by signaling through TACI and BAFF-R (19).
The sequences of BAFF and APRIL have been previously identi-
fied in rainbow trout (Oncorhynchus mykiss) (20), along with that 
of a further fish-specific molecule with close homology to both 
BAFF and APRIL designated as BALM (BAFF- and APRIL-like 
molecule). In addition, BAFF sequences have been reported in 
different teleost fish species including zebrafish (Danio rerio) (21), 
mefugu (Takifugu obscurus) (22), Japanese sea perch (Lateolabrax 
japonicus) (23), grass carp (Ctenopharyngodon idella) (24), yel-
low grouper (Epinephelus awoara) (25), miiuy croaker (Miichthys 
miiuy) (26), tongue sole (Cynoglossus semilaevis) (27), Nile tilapia 
(Oreochromis niloticus) (28), rock bream (Oplegnathus fasciatus) 
(29), and cartilaginous fish such as white-spotted catshark 
(Chiloscyllium plagiosum) (30), spiny dogfish (Squalus acanthias) 
(31), and small-spotted catshark (Scyliorhinus canicula) (32). 
Although recombinant BAFF proteins have been produced for 
some of these species (21–23, 25, 27–30), many of these stud-
ies have exclusively tested the effect of recombinant fish BAFF 
on B cell survival using mammalian B cells (21, 22, 25, 28, 30). 
Furthermore, those studies, which have concluded a capacity of 
BAFF to induce proliferation using teleost leukocytes, have not 
made a distinction between proliferation and survival as they 
have only determined increased numbers of leukocytes after 
BAFF treatment and have not clearly established that the cells 
showing increased survival or proliferating were in fact B cells 
(21–23, 27, 29). Consequently, the role that BAFF plays on B cell 
function in teleost remains largely unknown.
Although, evolutionarily, fish constitute the first group of 
animals in which all the key components of adaptive immunity 
are present, some unique structural features of the immune 
system predict important functional differences between fish 
and mammalian B  cells. In teleost, the spleen constitutes the 
main secondary immune organ in the absence of lymph nodes. 
However, the splenic white pulp is poorly developed in compari-
son to mammals and no GCs are apparent (33). Additionally, fish 
contain only three immunoglobulin classes, namely IgM, IgD, 
and IgT (designated as IgZ in some species) (34). Since IgT is 
a teleost fish-specific Ig that seems to be specialized in mucosal 
immunity (35, 36) and IgT+ B  cells constitute a distinct linage 
(35), no class switch recombination has ever been reported in 
fish. Furthermore, teleost B  cells share many features of mam-
malian B1 cells, as for example, long-term survival in cell culture, 
a high phagocytic capacity (37, 38), constitutive expression of 
many PRRs (39, 40), and expression of homolog molecules to 
B1-specific cell markers (41). As a result, the lack of teleost fol-
licular structures and the conservation of many innate features of 
fish B cells strongly suggest that fish B cell responses best resemble 
mammalian TI responses.
In this context, it is of great interest to establish how innate 
B cell stimulating cytokines, such as BAFF, control B cells before 
the appearance of follicular structures and this is what we have 
addressed in the current study using rainbow trout as a model. 
Our findings show that, in teleost, as in mammals, BAFF has no 
effect on B cell proliferation but is exclusively a survival factor for 
splenic B cells. Interestingly, both splenic IgD+IgM+ cells (exhibit-
ing a naïve B cell phenotype) and IgD−IgM+ cells (exhibiting a 
plasmablast phenotype) are expanded in the presence of BAFF 
and, consequently, IgM secretion is also augmented in these 
cultures. BAFF also increased the surface expression of MHC II 
in splenic B cells, but had no effect on their phagocytic capacity. 
Finally, we have established that, unlike the situation in mammals 
where BAFF is produced by cells of the innate immune system, 
a subpopulation of fish splenic B cells produce BAFF in physi-
ological conditions, revealing an ancient mechanism to regulate 
B cell functionality in teleost. Throughout evolution, this capac-
ity of B cells to produce BAFF has been lost, possibly upon the 
appearance of follicular structures that sustain B2 cell survival in 
physiological conditions, and only reappears in mammals during 
B cell proliferating disorders such as B cell lymphomas or autoim-
mune diseases.
MaTerials anD MeThODs
Production of recombinant rainbow Trout 
BaFF
The nucleotide sequence corresponding to the extracellular 
domain of the rainbow trout BAFF sequence (GenBank Accession 
number DQ218467.1) together with an N-terminal 6x histidine 
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tag was synthetized and subcloned into the E3 expression vec-
tor (Abyntek). The recombinant plasmid was transformed into 
BL21 cells and a kanamycin-resistant single positive colony was 
then incubated at 37°C in Luria-Bertani media. When the OD600 
reached 0.6, 0.1  mM of isopropyl β-d-thiogalactoside (IPTG, 
Sigma-Aldrich) was added to induce protein production. After 
16  h, cells were harvested, lysed by sonication, and dissolved 
using urea. Thereafter, BAFF was obtained through the use of 
Nickel columns (Sigma-Aldrich). The BAFF-containing fractions 
were pooled, refolded, filtered through 0.22 μm, and resuspended 
in storage buffer (50 mM Tris–HCl, 150 mM NaCl, 10% glycerol, 
0.5 M l-arginine, and 2 mM DTT, pH 8.5). Protein concentra-
tion was determined in a BCA protein assay (Thermo Fisher 
Scientific) and the recombinant rainbow trout BAFF (0.3 mg/ml) 
was aliquoted and stored at −80°C until used. An irrelevant pro-
tein with a similar molecular weight to that of recombinant BAFF 
(20.7 kDa), also bearing an N-terminal His tag was produced in 
the same conditions (C-His) and was used as a functional control.
generation of a Mouse pab against 
rainbow Trout BaFF
Six-week-old BALBc mice were immunized with 60 μg of recom-
binant BAFF protein emulsified in Montanide ISA 763 A VG 
adjuvant (Seppic) at a 1:1 ratio (volume). A 60 μg booster shot 
emulsified in Montanide ISA 763 A VG was given at days 15 and 
30 postimmunization. Mice were sacrificed 10 days after the last 
boost and peripheral blood was collected and serum obtained. 
The antibody was purified from the serum by immunoglobulin 
affinity using protein G-sepharose columns (Thermo Fisher 
Scientific), following manufacturer’s instructions. Recombinant 
rainbow trout BAFF protein was used to test the specificity of 
the anti-BAFF polyclonal antibody against the pre-immune 
serum from the same animal, by Western blot. SDS-PAGE and 
Western blots were performed as previously described (42). For 
some applications, purified anti-BAFF antibody was biotinylated 
using EZ-link NHS Biotin (Thermo Fisher Scientific), follow-
ing manufacturer’s instructions. The protocol described for the 
generation of the polyclonal antibody described comply with the 
Guidelines of the European Union Council (2010/63/EU) for 
the use of laboratory animals and were previously approved by the 
Ethics committee from the Instituto Nacional de Investigación y 
Tecnología Agraria y Alimentaria (INIA; Code CEEA 2012/008).
experimental Fish
Healthy specimens of female rainbow trout (O. mykiss) 
of approximately 50–70  g were obtained from Centro de 
Acuicultura El Molino (Madrid, Spain). Fish were maintained at 
the Animal Health Research Center (CISA-INIA) laboratory at 
16°C with a re-circulating water system and 12:12-h light:dark 
photoperiod. Fish were fed twice a day with a commercial diet 
(Skretting, Spain). Prior to any experimental procedure, fish were 
acclimatized to laboratory conditions for 2 weeks and, during this 
period, no clinical signs were ever observed. The experiments 
described comply with the Guidelines of the European Union 
Council (2010/63/EU) for the use of laboratory animals and were 
previously approved by the Ethics committee from the Instituto 
Nacional de Investigación y Tecnología Agraria y Alimentaria 
(INIA; Code CEEA 2011/044).
leukocyte isolation
Rainbow trout were killed by benzocaine (Sigma-Aldrich) over-
dose and blood was extracted with a heparinized needle from the 
caudal vein and diluted 10 times with Leibovitz medium (L-15, 
Invitrogen) supplemented with 100  IU/ml penicillin together 
with 100  μg/ml streptomycin (P/S, Life Technologies), 10  U/
ml heparin (Sigma-Aldrich), and 5% fetal calf serum (FCS, Life 
Technologies). Spleen, head kidney, hindgut, skin, and peritoneal 
exudates were then collected. Single cell suspensions from spleen, 
head kidney, and peritoneum were obtained using 100 μm nylon 
cell strainers (BD Biosciences). The hindgut samples were opened 
lengthwise, washed in phosphate-buffered saline (PBS), and cut 
into small pieces. The skin was cut off the fish with a scalpel, 
then, the muscle tissue was removed and the skin was further 
cleaned with ice-cold PBS and cut into small pieces. For hindgut 
and skin, the cell extraction procedure started with one round of 
30 min agitation at 4°C in L-15 medium with P/S and 5% FCS, 
followed by an agitation in PBS with 1 mM EDTA and 1 mM DTT 
for 30 min. Finally, the tissues were digested with 0.15 mg/ml of 
collagenase (Sigma) in L-15 for 1.5 h at 20°C. All cell suspensions 
were placed onto 30/51% discontinuous Percoll (GE Healthcare) 
density gradients and centrifuged at 500 × g for 30 min at 4°C. The 
interface cells were collected and washed twice in L-15 containing 
5% FCS. When required, leukocytes were incubated in the pres-
ence of TNP-LPS (Biotools) at a final concentration of 5 μg/ml 
and/or recombinant rainbow trout BAFF at a final concentration 
of 3 μg/ml. A wide range of doses of these stimuli were tested and 
the optimal doses were selected based on their effect on B cell 
survival (data not shown).
Flow cytometry
The anti-trout IgD [mAb mouse IgG1 coupled to R-phycoerythrin 
(R-PE), 5  μg/ml], the anti-trout IgM [1.14 mAb mouse IgG1 
coupled to fluorescein (FITC) or to allophycocyanin (APC), 
1 μg/ml], and the anti-trout MHC II β-chain (mAb mouse IgG1 
coupled to APC, 2 μg/ml) used in this study have been previ-
ously characterized (43, 44). All the mAbs were fluorescently 
labeled using fluorescein, R-PE, or APC Lightning-Link labeling 
kits (InnovaBiosciences), following manufacturer’s instructions. 
Spleen leukocytes were incubated with specific antibodies for 
30 min in the case of anti-IgM or anti-MHC, or 45 min in the 
case of anti-IgD, washed three times with staining buffer (PBS 
containing 1% FCS and 0.5% sodium azide), and analyzed. A 
biotinylated version of anti-BAFF (pAb mouse IgG, 1 μg/ml) was 
used to determine endogenous BAFF expression by leukocytes. 
To carry this out, cells were incubated for 30 min with biotinylated 
anti-BAFF pAb, then washed three times with staining buffer, and 
incubated for another 30 min with streptavidin-FITC (Thermo 
Fisher Scientific). In all cases, isotype controls for mouse mAbs 
and anti-BAFF pAb (BD Biosciences) were tested in parallel to 
discard unspecific binding of the Abs. All the incubations were 
performed at 4°C. After incubation with the corresponding 
stimuli, samples were incubated with 10 μg/ml propidium iodide 
(Thermo Fisher) for 5  min in the dark, and cell viability was 
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analyzed in our experimental conditions (n = 3). All samples were 
analyzed on a FACSCalibur flow cytometer (BD Biosciences) 
equipped with CellQuest Pro software. Flow cytometry analysis 
was performed with FlowJo 10 (TreeStar).
BaFF-Binding assay
For the analysis of BAFF binding to trout B cells, splenocytes were 
incubated for 1 h at 4°C with recombinant BAFF or C-His (3 μg/
ml each) or with a stock of BAFF, which had been previously 
incubated with anti-BAFF pAb (protein:Ab molar ratio 1:10). 
After that, cells were washed with staining buffer and labeled with 
an FITC-anti-His mAb (Thermo Fisher Scientific) together with 
APC-anti-IgM mAb (1 μg/ml) for 30 min at 4°C, then washed 
again, and analyzed by flow cytometry.
Tissue sampling for the analysis of BaFF 
Transcription
Rainbow trouts were killed by benzocaine overdose. Blood was 
extracted with a heparinized needle from the caudal vein. Spleen, 
head kidney, skin, heart, gills, thymus, hindgut, and liver were 
then collected and placed in Trizol (Thermo Fisher Scientific) 
after transcardial perfusion using teleost Ringer solution pH 
7.4 with 0.1% procaine in order to remove all the circulating 
blood from the tissues (39, 45). Total RNA was extracted using a 
combination of Trizol and RNAeasy Mini kit (Qiagen) as previ-
ously described (43). RNA was also extracted from the RTS11 
rainbow trout monocyte–macrophage cell line (46) and the 
RTG2 fibroblast cell line (ATCC CCL-55) following the same 
procedure. The expression of individual genes was normalized 
to relative expression of trout EF-1α and the expression levels 
were calculated using the 2−ΔCt method, where ΔCt is determined 
by subtracting the EF-1α value from Ct of the targeted gene as 
previously described (43). RNA pellets were eluted from the 
columns in RNase-free water, quantified in a Nanodrop 1000 
spectrophotometer (Thermo Scientific), and stored at −80°C 
until used. RNAs were treated with DNase during the purifica-
tion process to remove genomic DNA that might interfere with 
the PCR reactions and then used to obtain cDNA in each sample 
using the Bioscript reverse transcriptase (Bioline Reagents 
Ltd.) and oligo (dT)12–18 (0.5  μg/ml) following manufacturer’s 
instructions. Minus reverse transcriptase controls were included 
in all the assays to rule out amplification of genomic DNA. The 
resulting cDNA was diluted 1:5 in DNAse-free water and stored at 
−20°C. Transcription levels were analyzed by real-time PCR with 
a LightCycler® 96 System (Roche) using FastStart Essential DNA 
Green Master reagents (Roche) and specific primers (Table S1 in 
Supplementary Material). Each sample was measured under the 
following conditions: 10 min at 95°C, followed by 40 amplification 
cycles (10 s at 95°C, 10 s at 60°C, and 10 s at 72°C). The expres-
sion of individual genes was normalized to relative expression 
of trout EF-1α and the expression levels were calculated using 
the 2−ΔCt method, where ΔCt is determined by subtracting the 
EF-1α value from Ct of the targeted gene as previously described 
(43). Negative controls with no template were included in all the 
experiments. A melting curve for each PCR was determined by 
reading fluorescence every degree between 60 and 95°C to ensure 
that only a single product had been amplified.
gene expression analysis in Facs-
isolated Populations
To analyze BAFF transcription levels, IgM+ B cells were isolated 
from spleen, head kidney, blood, and peritoneum. To carry this 
out, cells were FACS isolated with specific mAbs against IgM, as 
previously described (39). CD8+ T  cells (CD8+MHC II− cells) 
were isolated from spleen, and CD8+ DCs (myeloid CD8+MHC 
II+) were obtained from skin using specific mAbs against CD8 and 
MHC II, as previously described (44). To analyze the gene expres-
sion pattern of B cell subsets from the spleen, splenocytes were 
stained using mAbs against IgD and IgM, as described above, and 
IgD+IgM+ and IgD−IgM+ B cells were FACS isolated. To analyze 
the transcriptional levels of MHC II and Blimp-1 on BAFF-treated 
B  cells, splenocytes were stained using a mAb against IgM, as 
described above, and IgM+ B cells were FACS isolated. In all cases, 
FACS isolation was performed using a BD FACSAria III (BD 
Biosciences). We analyzed the purity of the isolated populations 
by flow cytometry after sorting and only those samples showing 
a purity level higher than 95% were used for qPCR analysis. RNA 
isolation and expression of individual genes was performed as 
previously described (44). Briefly, total RNA from FACS-isolated 
cells was isolated using the Power SYBR Green Cells-to-Ct Kit 
(Thermo Fisher Scientific) following manufacturer’s instructions. 
RNAs were treated with DNase during the process to remove 
genomic DNA that might interfere with the PCR reactions. 
Reverse transcription was also performed using the Power SYBR 
Green Cells-to-Ct Kit according to manufacturer’s instructions. 
Minus reverse transcriptase controls were included in all the 
assays to rule out amplification of genomic DNA. To evaluate 
the levels of transcription of BAFF in these samples, real-time 
PCR was performed with a LightCycler® 96 System instrument 
using SYBR Green PCR core Reagents (Applied Biosystems) 
and specific primers (Table S1 in Supplementary Material). Each 
sample was measured in duplicate under the following condi-
tions: 10 min at 95°C, followed by 45 amplification cycles (15 s 
at 95°C and 1 min at 60°C). A melting curve for each PCR was 
also included to ensure only a single product had been amplified. 
The expression of individual genes was normalized to the relative 
expression of trout housekeeping gene EF-1α elongation factor 
as described above.
Phagocytic activity
For the analysis of phagocytosis, spleen leukocytes were seeded 
in 24-well plates (Nunc) at a cell density of 1 × 106 cells per well 
and incubated for 24 h at 20°C with BAFF (3 μg/ml), TNP-LPS 
(5 μg/ml), a combination of both, or left unstimulated (control), 
and then incubated for another 16  h at 20°C with fluorescent 
polystyrene-based particles (FluoSpheres® Microspheres, 1.0 μm, 
Crimson Red Fluorescent 625/645, 2% solids; Life Technologies) 
at a cell:bead ratio of 1:10 or without beads as negative controls. 
Cells were harvested using a standard cell scraper (Corning). 
Non-ingested beads were removed by centrifugation (100 ×  g 
for 10 min at 4°C) over a cushion of 3% (weight/volume) bovine 
serum albumin [(BSA), Fisher Scientific] in PBS supplemented 
with 4.5% (weight/volume) d-glucose (Sigma). Cells were resus-
pended in staining buffer, labeled with an anti-IgM mAb fluores-
cently labeled with FITC, and analyzed on a FACSCalibur flow 
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cytometer equipped with CellQuest sofware (BD Biosciences). 
The analysis was also performed with FlowJo 10.
B cell Proliferation
The BrdU Flow Kit (Becton Dickinson) was used to measure 
the proliferation of IgM+ B  cells in response to BAFF and/or 
TNP-LPS following manufacturer’s instructions. Splenocytes at 
a concentration of 2 × 106 cells/ml were incubated for 3 days at 
20°C with the stimuli as described above. Bromodeoxyuridine 
(BrdU, 10 μM) was then added to the cultures and the cells were 
incubated for an additional 24  h. The cells were collected and 
stained with APC-anti-IgM mAb (1 μg/ml). Briefly, to analyze 
incorporation of BrdU, cells were then fixed and permeabilized 
with Cytofix/Cytoperm Buffer for 15 min on ice, then incubated 
with Cytoperm Permeabilization Buffer Plus for 10 min on ice, 
and re-fixed with Cytofix/Cytoperm Buffer for 5 min at RT. Cells 
were then incubated with DNase (30 μg/106 cells) for 1 h at 37°C 
to expose the incorporated BrdU. Finally, cells were stained with 
FITC anti-BrdU antibody for 20 min at RT and analyzed by flow 
cytometry.
confocal Microscopy
Splenocytes were obtained as described above. To establish BAFF 
binding to trout IgM+ B  cells, leukocytes were incubated with 
3 μg/ml of recombinant BAFF in L-15 media supplemented with 
5% FCS. After 1 h at 20°C, the cells were washed with serum-
free L-15 medium, seeded on poly l-lysine coated slides, and 
incubated at 20°C for 30  min. After gently washing with PBS, 
the slides were fixed in 4% PFA for 15 min at RT. The samples 
were permeabilized for 1 h at RT with permeabilizing solution 
(TBS buffer, pH =  7.5, containing 0.01% BSA, 0.02% Tween-
20, and 0.5% saponin) and then incubated for 1  h at RT with 
blocking solution (TBS buffer, pH = 7.5, containing 0.01% BSA, 
0.02% Tween-20, 0.5% saponin, and 10% rabbit and goat serum). 
Fixed cell slides were then incubated with APC-anti-IgM mAb 
(1 μg/ml) and an FITC-anti-His mAb for 30 min. Samples were 
counterstained with 1 μg/ml DAPI (Sigma).
To analyze BAFF production by IgM+ B cells, leukocytes were 
suspended in serum-free L-15 medium, seeded on poly l-lysine 
coated slides, and incubated at 20°C for 30 min. After gently wash-
ing with PBS, the slides were fixed, permeabilized, and washed as 
described above. Fixed cell slides were then incubated with anti-
BAFF pAb coupled to biotin for 30 min, then gently washed, and 
incubated with APC-anti-IgM (1 μg/ml) and streptavidin-FITC 
(Thermo Fisher Scientific) for 30  min. Samples were counter-
stained with 1 μg/ml DAPI (Sigma). In all cases, laser scanning 
confocal microscopy images (0.3 μm thickness) were acquired 
with an inverted Zeiss Axiovert LSM 880 microscope. Images 
were analyzed with Zen 2.0 (Carl Zeiss) and Fiji (NIH) software 
packages.
elisPOT analysis
ELISPOT was used to quantify the number of IgM-secreting 
B cells. Splenocytes were incubated with BAFF (3 μg/ml), and/
or TNP-LPS (5  μg/ml), or left unstimulated (control) at 20°C 
for 48  h. ELISPOT plates containing Inmobilon-P membranes 
(Millipore) were activated with 70% ethanol for 30  s, coated 
with anti-trout IgM mAb (clone 4C10) at 2 μg/ml in PBS, and 
incubated overnight at 4°C. To block non-specific binding to the 
membrane, plates were then incubated with 2% BSA in PBS for 
2 h at RT. Thereafter, leukocytes from individual fish were added 
to the wells in triplicate at a concentration of 1 × 105 cells per 
well. After 24 h of incubation at 20°C, cells were washed away 
five times with PBS and plates were blocked again with 2% BSA 
in PBS for 1 h at RT. After blocking, biotinylated anti-trout IgM 
mAb (clone 4C10) was added to the plates and incubated at 1 μg/
ml for 1 h at RT. Following additional washing steps (five times in 
PBS), the plates were developed using streptavidin-HRP (Thermo 
Scientific) at RT for 1 h, washed again with PBS, and incubated 
with 3-amino 9-ethylcarbazole (Sigma-Aldrich) for 30 min at RT 
in the dark. Substrate reaction was stopped by washing the plates 
with tap water. Once the membranes had dried, they were digi-
tally scanned and spot counts determined by the ImmunoSpot 
Series 45 Micro ELISPOT Analyzer.
statistical analysis
Statistical analyses were performed conducting one-way ANOVA 
to analyze whether significant differences exist between the means 
of all the experimental groups included in each assay. When 
significant differences were found, we then performed a post hoc 
multiple comparison Tukey’s test. The differences between the 
mean values were considered significant on different degrees, 
where *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.005. The analysis was 
performed with XLSTAT statistical software for Excel (Microsoft) 
and GraphPad Prism 6 software (GraphPad).
resUlTs
recombinant BaFF Binds Teleost B cells
The soluble domain of rainbow trout BAFF was produced in E. 
coli, purified under denaturing conditions, and refolded in vitro 
(Figure S1A in Supplementary Material). To confirm that LPS 
contamination in the recombinant protein was negligible, we 
verified that recombinant BAFF had no effects on the expression 
of IL-1β on splenocytes, since this gene has been shown to be 
highly upregulated by bacterial LPS in this system (47, 48) (Figure 
S1B in Supplementary Material).
Next, we verified that splenic IgM+ B cells were able to bind 
recombinant BAFF. For this, we incubated total leukocytes from 
the spleen of unstimulated fish with recombinant histidine-
tagged BAFF for 1 h, then labeled the cells with an anti-IgM mAb 
and an anti-His mAb, and performed flow cytometry analysis. We 
verified that an average 6.5% of the splenic lymphocytes-bound 
recombinant BAFF and more than half of these cells were IgM+ 
B  cells (Figures  1A,B). These BAFF-binding IgM+ B  cells cor-
respond to an average 8.4% of the IgM+ B cell population, whereas 
only 3.9% of the IgM− B  cells were binding the recombinant 
cytokine (Figure 1C). To confirm that BAFF binding to B cells 
was specific, we blocked the union with a polyclonal antibody 
raised against recombinant trout BAFF in mice. This polyclonal 
antibody was highly specific and recognized recombinant BAFF 
protein in Western blot (Figure S2A in Supplementary Material) 
and also membrane BAFF present on spleen lymphocytes by 
FigUre 1 | rainbow trout B cell-activating factor (BaFF) binds to igM+ B cells. To analyze the specific binding of BAFF to IgM+ B cells, freshly isolated 
splenic leukocytes were incubated with recombinant histidine-tagged BAFF protein (3 μg/ml) or an irrelevant 20 kDA histidine-tagged protein (C-His, 3 μg/ml) for 1 h. 
In parallel, cells were also cultured for 1 h with recombinant BAFF protein, which had been previously incubated for 1 h with an anti-BAFF pAb (molar ratio 1:10). 
Thereafter, cells were stained with an anti-IgM mAb together with an anti-His mAb, or with isotype control mAbs, and analyzed by flow cytometry. Dot plots from one 
representative experiment are shown (a) and percentages of BAFF-binding IgM− and IgM+ cells are indicated in the plots. The quantification of BAFF binding on 
IgM− and IgM+ B cells is also shown (B) as mean + SD (n = 9, three experiments containing three animals each). (c) The percentages of cells binding BAFF within 
the IgM− and IgM+ compartments were also calculated and are plotted as pie charts (mean ± SD, n = 9, three independent experiments containing three animals 
each). Dead cells were not excluded during the flow cytometry analysis, but cell viability was higher than 99% for IgM+ B cells and higher than 95% for other 
lymphocytes on these experimental settings (Figure S4A in Supplementary Material). (D) Total leukocytes from spleen were incubated with recombinant BAFF (3 μg/
ml) for 1 h, then plated onto poly-l-lysine-coated glass slides, fixed and labeled with anti-IgM (shown as red) and anti-His (BAFF, shown as green) antibodies, then 
counterstained with DAPI (blue), and analyzed by fluorescence microscopy. A representative general overview is shown (upper row) (scale bar, 20 μm) and the 
amplification detail of a single cell (lower row) (scale bar, 1 μm). IgM+BAFF− and IgM+BAFF+ cells on preparations of spleen leukocytes from eight fish were quantified 
and plotted (right bar plot) and shown as mean + SD (n = 150 cells).
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flow cytometry (Figure S2B in Supplementary Material). In the 
splenocyte BAFF-binding assays, when recombinant BAFF was 
incubated with the polyclonal anti-BAFF before its addition to 
splenocytes, its binding decreased to nearly undetectable levels, 
both in IgM+ and IgM− populations (Figures  1A,B), demon-
strating the specificity of the binding and that of the polyclonal 
antibody. To rule out a possible binding of BAFF through the 
histidine tag in an unspecific fashion, we incubated splenocytes 
with an irrelevant protein of the same molecular weight carrying 
a histidine tag, and as shown in Figures 1A,B, only a negligible 
binding was observed. An additional control was included to 
exclude the possibility of the anti-BAFF pAb blocking the access 
of the anti-His mAb to the His tag instead of BAFF binding to the 
cells, we incubated spleen leukocytes with BAFF for 1 h, and then 
incubated these cells with anti-BAFF pAb for 1 h. In this case, we 
did not see any difference on BAFF binding, thus demonstrating 
that the pAb anti-BAFF blocks the binding of BAFF to the cells 
but does not interfere with the access of the anti-His to the His 
tag once BAFF is bound to the cells (Figure S3 in Supplementary 
Material). To visualize BAFF binding to IgM+ B cells, we incu-
bated total leukocytes from the spleen of unstimulated fish with 
recombinant histidine-tagged BAFF for 1 h, and then fixed the 
cells to analyze them through confocal microscopy. We further 
verified that spleen IgM+ B  cells co-stained with recombinant 
BAFF (Figure 1D). In this case, the average number of BAFF+ cells 
observed within the IgM+ compartment was 39.2%, which was 
higher than that seen for extracellular binding analyzed by flow 
cytometry. The reason for this difference is that, through confocal 
microscopy, we are able to observe both extracellular (binding) 
and intracellular (internalization) staining, however, we cannot 
exclude that part of the internalization of BAFF is due to receptor-
independent mechanisms such as pinocytosis. All together, these 
results unequivocally demonstrate that a subpopulation of trout 
splenic B cells is able to bind to soluble BAFF.
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spleen B cells express BaFF 
constitutively in Teleost
Prior to the determination of BAFF functionality in trout B cells, 
we conducted a series of experiments to study, which cell types 
were producing BAFF in physiological conditions. First, we 
analyzed the transcription of BAFF throughout the different 
tissues in unstimulated rainbow trout. BAFF mRNA levels were 
higher in the spleen, followed by other immune tissues such as 
peripheral blood and the head kidney (the main hematopoietic 
organ in fish) (Figure  2A). Intermediate BAFF transcript lev-
els were observed in skin, heart, gills, thymus, and gut, while 
very low transcript levels were found in the liver (Figure 2A). 
BAFF transcription was then examined in different immune 
cell subsets. As expected, CD8+ DCs from skin expressed high 
levels of BAFF (Figure 2B), but to our surprise, these levels were 
comparable to those observed in IgM+ B cells from spleen, head 
kidney, and blood (Figure 2B). Intermediate BAFF expression 
levels were found in IgM+ B  cells from other peripheral tis-
sues, such as the peritoneal cavity or the hindgut. On the other 
hand, CD8+ T cells from the spleen contained low amounts of 
BAFF mRNA, while no BAFF transcription was observed in the 
RTS11 monocyte-macrophage or the RTG2 fibroblast cell lines 
(Figure 2B).
Because mammalian unstimulated B  cells do not express 
BAFF to confirm the transcriptomic results that suggested that 
teleost naïve B cells produce this cytokine, we studied the pres-
ence of BAFF in spleen IgM+ cells through flow cytometry using 
the anti-BAFF polyclonal antibody developed. Approximately 
14% of the cells within the myeloid gate (large size and high 
complexity) were producing BAFF, which could indicate BAFF 
production by DCs and macrophages (Figures  2C,D). Within 
the lymphoid gate, we studied BAFF production in IgM+ and 
IgM− cell populations, verifying that a fraction of IgM+ B cells 
express endogenous BAFF on the cell surface (Figures 2C,D). In 
average, almost 7% of the splenic IgM+ B cells produced BAFF, 
whereas only around 3.7% of the IgM− lymphocytes produced 
the cytokine (Figures 2C,D). These results reveal that within the 
BAFF-producing leukocyte compartment, although the majority 
of the cells producing BAFF were myeloid cells (55.4 ± 19.9%), 
28.1 ± 4.9% of the BAFF-producing cells among splenocytes were 
IgM+ B cells (Figure 2F). Furthermore, the levels of membrane 
BAFF seen in IgM+ B cells, estimated by the mean fluorescence 
intensity (MFI) values, were equivalent to those found in myeloid 
cells and were much higher than those seen in IgM− leukocytes 
(Figure  2E). When the anti-BAFF pAb was premixed with 
recombinant BAFF, we did not observe any binding of the 
antibody to either lymphoid or myeloid cells, thus confirming 
that we were observing a specific staining for membrane BAFF 
(Figure S2C in Supplementary Material). In order to visualize 
IgM+ B cells-expressing BAFF, splenocytes were fixed and labeled 
with anti-IgM and anti-BAFF antibodies and analyzed by laser 
scanning confocal microscopy. We observed that IgM+ B  cells 
from non-stimulated animals exhibited a positive staining for 
BAFF (Figure 2G) in a proportion similar to that seen by flow 
cytometry. These results demonstrate that teleost spleen B cells 
differ from mammalian B cells in their capacity to produce BAFF 
in physiological conditions.
BaFF Upregulates Membrane Mhc-ii 
expression on B cells without altering 
Their antigen acquisition capacities 
through Phagocytosis
We studied whether BAFF could have an effect on the levels of 
surface MHC-II expression using a specific anti-trout MHC II 
antibody (44). Our results showed that, after incubation with 
BAFF, membrane MHC II levels increased over time on IgM+ 
B  cells reaching a significantly increased peak of expression at 
72 h (Figures 3A,B). We compared our results to those elicited by 
TNP-LPS, given the fact that LPS is a highly effective polyclonal 
activator of B cells from many species. Although TNP-LPS also 
upregulated MHC II surface expression, the levels induced by 
BAFF were significantly higher than those elicited by TNP-LPS 
and no synergies between TNP-LPS and BAFF were observed 
(Figure  3A). The increase of membrane MHC II expression 
was clear in cell cultures from all fish examined individually 
(Figure 3B) and was not observed when a histidine-tagged irrel-
evant protein with a similar molecular weight was used (Figure 
S5A in Supplementary Material).
To assess whether the increase on membrane MHC II level was 
a consequence of increased gene transcription, we analyzed MHC 
II transcription levels in sorted IgM+ B cells treated or not with 
recombinant BAFF for 24, 48, and 72 h. We found that MHC II 
mRNA levels were not upregulated by BAFF in sorted B cells at 
any time point analyzed (Figure 3C), suggesting that the effect of 
BAFF could be based on translocation of MHC II molecules to 
the plasma membrane or an increase of the half-life of membrane 
MHC II due to a potential activation of B cells (49).
Since rainbow trout B cells have been shown to have potent 
phagocytic capacities (37), and this peculiar trait strongly condi-
tions its antigen-presenting abilities, we aimed to study whether 
BAFF could also affect the phagocytic capacity of IgM+ B cells. In 
this occasion, we observed that BAFF did not alter the average 
percentage of phagocytic IgM+ B cells. TNP-LPS or a combination 
of BAFF with TNP-LPS did not affect the number of phagocytic 
IgM+ B cells either (Figures 3D,F). In parallel, the MFI of beads 
ingested by the IgM+ B cells was not affected by any of the stimuli 
tested (Figures 3E,F). Thus, our results suggest a role for BAFF 
in the regulation of B cell antigen presentation, through increased 
surface MHC II levels but without affecting antigen acquisition 
by phagocytosis.
BaFF has no Proliferative effects of Trout 
B cells
A few studies in fish have concluded a capacity of BAFF to induce 
proliferation of total leukocyte populations using methodological 
approaches that do not make a distinction between proliferation 
and survival (22, 23, 27, 29). Thus, in this study, we wanted to clearly 
address this issue and clarify whether fish BAFF has proliferative 
effects or, as in mammals, it is exclusively a survival factor. When 
the proliferative effects of BAFF were tested on IgM+ B cells from 
spleen by means of BrdU incorporation, we verified that BAFF is 
incapable of inducing proliferation of IgM+ B cells, with almost 
undetectable proliferation rates that were significantly lower than 
those elicited by TNP-LPS (Figures 4A,B). When TNP-LPS was 
FigUre 2 | B cell-activating factor (BaFF) expression in rainbow trout in physiological conditions. BAFF transcription levels were analyzed through 
real-time PCR in rainbow trout tissues (a) and FACS isolated cell subsets and in the RTS11 (macrophages) and RTG2 (fibroblasts) cell lines (B) the relative 
expression to the endogenous control EF-1α was calculated for each sample (shown as mean + SD, n = 6) (HK, head kidney; DCs, dendritic cells; Per, peritoneum). 
(c) Rainbow trout leukocytes isolated from spleen were stained with an anti-IgM mAb together with an anti-BAFF pAb and analyzed by flow cytometry. Lymphoid 
(blue gate) and myeloid (red gate) populations were gated and, then, IgM− (orange gate) and IgM+ (green gate) cells were further selected from the lymphoid 
population. A representative histogram showing the level of BAFF expression in each population is shown. The average percentage of BAFF+ cells within each 
compartment was also calculated (D) as well as the mean fluorescence intensity of BAFF on those populations (e) (shown as mean + SD, n = 9, three independent 
experiments containing three animals each). (F) The percentages of myeloid, lymphoid IgM−, and lymphoid IgM+ cells within the BAFF+ compartment were also 
calculated and are plotted as pie charts (mean ± SD, n = 9, three independent experiments containing three animals each). Dead cells were not excluded during the 
flow cytometry analysis, but cell viability was higher than 99% for IgM+ B cells and higher than 95% for other lymphocytes on these experimental settings (Figure 
S4B in Supplementary Material). (g) Total leukocytes from spleen were plated onto poly-l-lysine-coated glass slides, fixed and labeled with anti-IgM (red) and 
anti-BAFF (green) antibodies, then counterstained with DAPI (blue), and analyzed by fluorescence microscopy. Images from one representative experiment are 
shown (scale bar, 1 μm).
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combined with BAFF, the TNP-LPS-elicited proliferation was not 
further affected (Figures  4A,B), revealing that BAFF does not 
even have a synergistic effect on the B cell proliferation induced 
by TNP-LPS. In a similar way, but a lower extent, TNP-LPS was 
also able to induce the proliferation of an IgM− lymphocyte 
population, but this population did not proliferate in response to 
BAFF either (Figures 4A,B).
BaFF is a survival Factor for Trout igM+  
B cells
Despite the negligible proliferative effects, BAFF significantly 
increased the survival of IgM+ B  cells compared to control 
cultures, determined as the percentage of IgM+ cells in culture 
after 3 days, at levels comparable to those induced by TNP-LPS 
(Figures 5A,C). This increased survival was very consistent and 
FigUre 3 | continued
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FigUre 4 | rainbow trout B cell-activating factor (BaFF) has no lymphoproliferative effects. To test the effect of BAFF on IgM+ B cell proliferation, spleen 
leukocytes were incubated with BAFF (3 μg/ml), TNP-LPS (5 μg/ml), a combination of both, or left unstimulated (control) for 3 days at 20°C. After this time, cells 
were labeled with BrdU and incubated for a further 24 h. The percentage of proliferating (BrdU+) IgM+ B cells was then determined as described in Section “Materials 
and Methods.” Quantification of the proliferating IgM− and IgM+ populations is shown (a) as mean + SD (n = 12, from four independent experiments containing 
three animals each), together with a representative dot plot of the flow cytometry analysis (B) number of proliferating IgM− and IgM+ cells are also indicated within 
the dot plots. The numbers between brackets represent the total number of IgM+ cells in each case. Dead cells were not excluded during the flow cytometry 
analysis, but cell viability was higher than 99% for IgM+ B cells and higher than 95% for other lymphocytes on these experimental settings (Figure S4C in 
Supplementary Material). Statistical differences were evaluated by a one-way ANOVA followed by a multiple comparison Tukey’s test, where *p ≤ 0.05 and 
***p ≤ 0.005.
FigUre 3 | continued 
B cell-activating factor (BaFF) increases the expression of membrane Mhc ii without altering antigen acquisition by phagocytosis. (a) Spleen 
leukocytes were incubated with BAFF (3 μg/ml), TNP-LPS (5 μg/ml), a combination of both, or left unstimulated (control) for 24, 48, or 72 h at 20°C. After this time, 
cells were labeled with anti-IgM and anti-MHC II mAbs and analyzed by flow cytometry. Mean fluorescence intensity (MFI) for membrane MHC II was measured on 
IgM+ B cells and average values were plotted as mean + SD (left) (n = 12 from four independent experiments containing three animals each). Histograms from one 
representative experiment, showing MHC II MFI on IgM+ gated B cells are shown (right panels). (B) The MFI of MHC II for each individual fish under control or BAFF 
stimulation conditions for 72 h is also plotted. (c) Splenocyte cultures were treated with BAFF (3 μg/ml) or left unstimulated (control) for 24, 48, and 72 h, and then, 
RNA was extracted from IgM+ FACS isolated B cells, as described in Section “Materials and Methods.” The expression of MHC II relative to the endogenous control 
gene EF-1α was calculated for each sample and shown as mean + SD (n = 12, from four independent experiments containing three animals each). Splenocyte 
cultures were treated with BAFF (3 μg/ml), TNP-LPS (5 μg/ml), or left unstimulated (control) for 48 h, then incubated with Crimson Red fluorescent polystyrene beads 
(1 μm diameter) in a ratio of 1:10 (cell:beads) for 16 h, and then centrifuged through a 3% bovine serum albumin + 4.5% glucose gradient to remove adhered 
beads. The percentages of phagocytic cells within the IgM+ B cell compartment was determined (D) as well as the MFI of the beads internalized by IgM+ B cells in 
each condition (e) (n = 12, from four independent experiments containing three animals each). Dot plots from one representative experiment for each experimental 
condition are shown (F). Dead cells were not excluded during the flow cytometry analysis, but cell viability was higher than 99% for IgM+ B cells and higher than 
95% for other lymphocytes on these experimental settings (Figure S4C in Supplementary Material). Statistical differences were evaluated by a one-way ANOVA 
followed by a multiple comparison Tukey’s test, where **p ≤ 0.01 and ***p ≤ 0.005.
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was visualized in cell cultures from all fish examined individu-
ally (Figure 5B), but was not observed when an irrelevant pro-
tein with a similar weight and a histidine tag was used (Figure 
S5B in Supplementary Material). Interestingly, no synergistic 
effects were observed when splenocytes were incubated with 
BAFF together with TNP-LPS (Figures  5A,C). Although it 
would be very interesting to study the effect of BAFF on FACS-
isolated IgM+ B cells, no functional studies can be performed 
FigUre 5 | rainbow trout B cell-activating factor (BaFF) promotes B cell survival. Spleen leukocytes were incubated with recombinant BAFF (3 μg/ml), 
TNP-LPS (5 μg/ml), a combination of both, or left unstimulated (control) for 3 days at 20°C. After this time, cells were labeled with an anti-IgM mAb and analyzed by 
flow cytometry. The percentage of live IgM+ B cells among the lymphocyte gate was then determined. Quantification of average B cell survival is shown as 
mean + SD (a), as well as the percentage of survival for each individual fish under control or BAFF stimulation conditions (B) (n = 12, from four independent 
experiments containing three animals each). A representative dot plot for each experimental condition is also included (c). Dead cells were not excluded during the 
flow cytometry analysis, but cell viability was higher than 99% for IgM+ B cells and higher than 95% for other lymphocytes on these experimental settings (Figure 
S4C in Supplementary Material). Statistical differences were evaluated by a one-way ANOVA followed by a multiple comparison Tukey’s test, where **p ≤ 0.01.
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on isolated IgM+ B cells, since the only tool available for their 
isolation is an anti-IgM mAb, which triggers their activation 
through BCR cross-linking. Thus, to further demonstrate 
that BAFF had a direct impact on IgM+ and to rule out that 
the increase on the number of IgM+ cells mediated by BAFF 
was due to a negative effect of the cytokine on IgM− cells, we 
conducted a similar study, this time also analyzing the number 
of cells at time 0 h. Our experiments revealed that at time 0 h, 
the cultures contain a lymphocyte population that accounts for 
an average 81.9 ± 7.8% of the live cells. Although throughout 
culture, the number of lymphocytes decreased over time, 
the presence of BAFF in the medium promoted a significant 
increase in the number of total lymphocytes (Figures S6A,D in 
Supplementary Material). This increased survival was detected 
in the IgM+ compartment (Figures S6C,E in Supplementary 
Material) but not in the IgM− (Figures S6B,E in Supplementary 
Material), thus revealing that the pro-survival effects exerted 
by BAFF on IgM+ cells are not due to negative effects on other 
populations. These results demonstrate that teleost BAFF, as 
mammalian BAFF (50), is exclusively a survival factor for IgM+ 
B cells.
BaFF increases igM Production through 
increased survival of igM+-secreting cells
In mammals, BAFF has been shown to increase the secretion 
of IgM and IgG in the absence of immunization (51). Thus, we 
aimed to establish if recombinant trout BAFF could increase IgM 
secretion in splenocyte cultures. To carry this out, we incubated 
splenocytes for 48 h with BAFF and/or TNP-LPS, and after that 
time, we analyzed the number of IgM-secreting cells through 
ELISPOT. We observed a significant increase in the number of 
IgM-secreting cells after treatment with either BAFF or TNP-
LPS, or a combination of both (Figure  6A). This increased 
number of IgM-secreting cells induced by BAFF was visualized 
in cell cultures from all fish examined (Figure  6B), but was 
not observed when a histidine-tagged irrelevant protein with a 
similar molecular weight was used (Figure S5C in Supplementary 
Material). Since Blimp-1 is an essential factor for the terminal 
differentiation of plasma cells in mammals (52), the fact that no 
upregulation of Blimp-1 expression was observed in sorted IgM+ 
B  cells after treatment with BAFF (Figure  6C) suggested that 
IgM plasma cells were not differentiating from resting B cells in 
response to the cytokine. In mammals, BAFF has been shown 
FigUre 6 | B cell-activating factor (BaFF) increases the number of igM-secreting cells. (a) Splenocyte cultures were treated with BAFF (3 μg/ml), TNP-LPS 
(5 μg/ml), a combination of both, or left unstimulated (control) for 48 h and then plated in ELISPOT plates previously coated with anti-trout IgM mAb, for a further 
24 h. After incubation, cells were washed away and a biotinylated anti-trout IgM mAb was used to detect numbers of spot forming cells. Quantification of spot 
forming cells is shown as mean + SD (n = 12, from four independent experiments containing three animals each). (B) The number of IgM-secreting cells was also 
plotted for each individual fish under control or BAFF stimulation conditions. (c) Splenocyte cultures were treated with BAFF (3 μg/ml) or left unstimulated for 24 h 
and, then, RNA from IgM+ FACS-isolated B cells was extracted as described in Section “Materials and Methods.” The transcription of Blimp-1 relative to the 
endogenous control EF-1α was calculated for each sample and shown as mean + SD (n = 12, from four independent experiments containing three animals each). 
Statistical differences were evaluated by a one-way ANOVA followed by a multiple comparison Tukey’s test, where **p ≤ 0.01.
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to promote IgM secretion through increased survival of plasma 
cells (53), so it seemed plausible that the increase in the number 
of IgM-secreting cells in response to rainbow trout BAFF was a 
consequence of BAFF promoting the survival of a pre-existing 
IgM-secreting cell compartment (either plasmablasts or plasma 
cells) in the spleen. To test this hypothesis, we performed a 
double staining with anti-IgD and anti-IgM mAbs and analyzed 
the effect of BAFF on the survival of IgD+IgM+ cells and that of a 
small subpopulation of IgD−IgM+ B cells found in the spleen. We 
found that both IgD+IgM+ (Figures 7A,B) and IgD−IgM+ B cells 
(Figures 7A,C) had a significantly increased survival in the pres-
ence of BAFF, with consistent increases in all individual fish ana-
lyzed (Figures 7B,C). Because in mammals, activated B cells that 
start their differentiation toward plasmablasts/plasma cells lose 
IgD in the cell membrane (54), these two B cell subpopulations 
should correspond with naïve B cells (IgD+IgM+) and plasmab-
lasts/plasma cells (IgD−IgM+). Confirming this premise, we phe-
notypically characterized these two B cell subpopulations. First, 
we estimated the size of these cells by means of the MFI of their 
forward scatter by flow cytometry, since an increase of the cell 
size is a common feature of antibody-secreting cells (ASCs) (55). 
As expected, IgD−IgM+ presented a significantly larger size than 
IgD+IgM+ B cells (Figure 7D). Furthermore, we, FACS isolated 
both B cell subtypes from the spleen and extracted RNA in order 
to study their gene expression pattern. Naïve IgD+IgM+ B cells 
had undetectable levels of secreted IgM and high-membrane IgD 
(mb IgD) and Pax5 transcription levels (Figure 7E). On the other 
hand, IgD−IgM+ cells presented significantly lower levels of mb 
IgD and Pax5 that, along with high mRNA levels of the secreted 
form of IgM, point to this population as an ASC type. Moreover, 
levels of Blimp-1 were significantly higher in IgD−IgM+ cells 
than in naïve B  cells (Figure  7E). These results indicate that 
there is a tissue resident plasmablast/plasma cell population in 
the spleen of rainbow trout, and, as in mammals, IgM secretion 
is increased by BAFF through the increased survival of these 
IgM-secreting cells.
DiscUssiOn
Fish are poikilotherm animals that regulate their metabolism in 
response to external temperature. Consequently, their immune 
system is also dependent on environmental conditions and even 
though teleost fish are the first animal group in which the complete 
adaptive immune machinery is present, at low temperatures, such 
as those at which salmonids usually live, these specific responses 
are significantly delayed. This, together with the lack of follicular 
structures in their immune organs, anticipates that, in teleost, 
the components of the adaptive immune system still retain many 
innate features and are closely dependent on innate regulatory 
factors. Given the fact that, in mammals, BAFF is a cytokine 
produced by innate cells upon antigen sensing, to regulate the 
survival and differentiation of B cells, especially at extrafollicular 
foci (56), we hypothesized that teleost B  cell function will be 
tightly regulated by BAFF. Thus, in the current work, we have 
undertaken an extensive characterization of the effects of BAFF 
on the functionality of teleost B cells. Before undertaking these 
functional studies, we performed a transcriptional analysis to 
study BAFF mRNA levels throughout the different fish tissues 
in physiological conditions. We found that BAFF expression 
was highest in spleen, as reported in other fish species, with the 
FigUre 7 | B cell-activating factor (BaFF) promotes the survival of naïve B cells and igM-secreting cells. (a) Spleen leukocytes were incubated with 
recombinant BAFF (3 μg/ml) or left unstimulated (control) for 3 days at 20°C. After this time, cells were labeled with anti-IgD and anti-IgM mAbs and analyzed by flow 
cytometry. The percentage of live IgD+IgM+ and IgD−IgM+ B cells among the lymphocyte gate was then determined. Number of cells is annotated within the gates of 
the representative dot plots shown. Average survival of IgD+IgM+ (B) and IgD−IgM+ (c) B cell survival is shown (left panels) as well as the percentage of surviving 
B cells for each individual fish under control or BAFF stimulation conditions [(B,c), right panels]. (D) IgD+IgM+ and IgD−IgM+ B cells were gated and the mean 
fluorescence intensity (MFI) for their forward scatter (FSC) determined (n = 12, from four independent experiments containing three animals each). (e) IgD+IgM+ and 
IgD−IgM+ B cells from the spleen were FACS isolated and RNA extracted. The transcription levels of membrane IgD (mb IgD), secreted IgM (sec IgM) Pax-5, and 
Blimp-1 relative to the endogenous control EF-1α were calculated for each sample and shown as mean + SD (n = 9, from three independent experiments 
containing three animals each). Dead cells were not excluded during the flow cytometry analysis, but cell viability was higher than 99% for IgM+ B cells and higher 
than 95% for other lymphocytes on these experimental settings (Figure S4C in Supplementary Material). Statistical differences were evaluated by a one-way ANOVA 
followed by a multiple comparison Tukey’s test, where **p ≤ 0.01 and ***p ≤ 0.005.
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exception of miiuy croaker, species in which highest BAFF mRNA 
levels were observed in skin (26). Consequently, our functional 
assays were performed with splenic IgM+ B cells.
In addition to providing an extensive characterization of 
B cell functions modulated by BAFF in teleost fish, the present 
study reports a major finding: the fact that, in teleost, a subset 
of B cells produces BAFF in physiological conditions. This result 
was confirmed through real-time PCR analysis, flow cytometry, 
and confocal imaging using a specific mouse polyclonal antibody 
against recombinant trout BAFF, previously characterized. 
Although only 7% of the IgM+ B cells produce BAFF as established 
by flow cytometry, given the high number of IgM+ B cells among 
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splenocytes, this population accounts for approximately 28% of 
the cells producing BAFF pointing to an important contribution 
of this population on the homeostasis of the spleen. Of course, 
it would be possible that some of the B cells in our cultures have 
been previously exposed to an antigen as the fish used in our 
study were obtained from a fish farm. It must be noted that the 
BAFF-producing IgM+ B cells displayed a phenotype of resting 
mature B cells with high IgD expression on the cell membrane 
and transcription of surface IgM and IgD at high levels (data 
not shown), but we cannot discard that some of these cells may 
be antigen-experienced B  cells, or even plasmablasts/plasma 
cells, given the fact that IgM-producing plasmablasts retain IgM 
on the cell membrane (57, 58). In mice and humans, BAFF is 
produced by macrophages, DCs, follicular DCs, stimulated 
neutrophils, and at low levels by T cells, but is never produced 
by resting B cells (3, 8, 59–62). Interestingly, B cells from B-cell 
chronic lymphocytic leukemia (63) or non-Hodgkin’s lymphoma 
(64), as well as B cells from patients with autoimmune disorders, 
namely rheumatoid arthritis (65), systemic lupus erythematosus 
(66), and primary Sjogren’s syndrome (67) also express BAFF, 
which rescues them from apoptosis in an autocrine loop. B1 cells 
and pre-B  cells have also been shown to contain higher levels 
of BAFF mRNA when compared to transitional, follicular, or 
MZ B cells (68). Remarkably, all rabbit spleen B cells, known to 
express CD5 and consequently regarded as a B1-like population, 
also express BAFF constitutively (69). Thus, the fact that teleost 
B cells produce BAFF, adds up to previous evidences that point 
to the great similarity between teleost B  cells and mammalian 
B1 populations. Interestingly, one of the distinctive features 
of B1 cells in all species, also shared by teleost B  cells, is their 
extended survival, and this is a characteristic also seen in B cell 
disorders in which autocrine BAFF production has been reported 
(63–66). Therefore, BAFF seems to be a key factor involved in the 
prolonged survival of B1 cells, and this is something that should 
be further investigated.
Before addressing the effects that BAFF provoked on teleost 
B cell functions, we analyzed the binding of BAFF to splenocytes. 
Our results showed that only 8.4% of the IgM+ B cells in the spleen 
were able to bind to recombinant BAFF; however, this percentage 
went up to 39.2% when both binding and internalization were 
determined through confocal microscopy. On the other hand, 
our experiments also revealed that 3.9% of the IgM− cells in the 
rainbow trout spleen also bound recombinant BAFF. Taking into 
account that IgT+ B cells in the rainbow trout spleen constitute 
25% of the total B cell population, it seems plausible that these 
IgM− lymphocytes binding BAFF are in fact IgT+ B cells and this 
is something that should be further explored. The percentage of 
B cells binding BAFF in the spleen revealed by our experiments 
seemed surprisingly low when compared to mammals as all 
splenic human (53) and mouse B cells (70) bind BAFF through 
BAFF-R, constitutively expressed on the cell surface of all resting 
B cells. We have very recently demonstrated that rainbow trout 
splenic IgM+ B cells transcribe not only BAFF-R but also BCMA 
(unpublished observations), thus it does not seem probable that 
this lower capacity to bind exogenous BAFF is a consequence of 
lower receptor expression levels. Another possible explanation 
is that BAFF receptors in trout B cells are already occupied by 
endogenous BAFF produced constitutively in the spleen. In rab-
bit, where B cells have been shown to actively produce BAFF, a 
low BAFF-binding capacity of splenic B cells has also been shown 
(69). The authors similarly concluded that these cells could not 
bind recombinant BAFF because the receptors were already 
occupied with endogenously synthesized BAFF.
B cells are professional antigen-presenting cells (APCs), which 
can endocytose antigens through the BCR and effectively present 
antigens to T cells in an MHC II context (71). In teleost, the high 
phagocytic capacity of B cells predicts an even higher antigen-
presenting capacity than that of mammalian B  cells (37), also 
being capable of presenting particulate antigens. Thus, initially, we 
studied the effect of BAFF on both the surface MHC II expression 
levels and the phagocytic capacities of splenic IgM+ B cells. We 
found that BAFF strongly increased surface MHC II expression 
in IgM+ cells, at levels much higher than those reached by TNP-
LPS-treated IgM+ B  cells. Because MHC II gene transcription 
was not upregulated in BAFF-treated cells, it appears that this 
increase is a consequence of increased translocation of MHC II 
molecules to the plasma membrane or an augmented half-life of 
membrane MHC II. A similar increase in surface MHC II expres-
sion in B cells in response to BAFF has also been demonstrated 
in mammals (18, 72). Although this increased surface MHC II 
expression anticipates an increased antigen-presenting capacity 
of B cells, the uptake of particulate antigen through phagocytosis 
was not affected by BAFF, indicating that BAFF only regulates the 
posterior antigen exposure on the membrane.
Focusing further on the effects that BAFF produces on teleost 
B cells, we observed insignificant proliferative effects, in contrast 
to the high proliferative effects exerted by TNP-LPS. Despite this, 
there was a significant increase in IgM+ B cell survival, at levels 
similar to those of TNP-LPS, demonstrating that in the absence 
of additional stimulation, rainbow trout BAFF is exclusively a 
survival factor for IgM+ B cells, as occurs in mammals (11, 50). 
This extended survival was observed in naïve B cell populations 
of the spleen that co-expressed IgM and IgD in the cell membrane 
as well as in plasmablasts that have lost surface IgD once the dif-
ferentiation process toward plasmablast/plasma cell has begun. 
This plasmablast/plasma cell phenotype was confirmed by the 
enlarged size of these IgD−IgM+ cells, together with the expres-
sion of the secreted form of IgM and the increased transcriptional 
levels of Blimp-1, thus indicating that BAFF can act in different 
splenic trout B cell subsets, as it happens in mammals (73). This 
is the first characterization of such B cell subpopulations in tel-
eost by means of surface IgD expression. The extended survival 
of these plasmablasts/plasma cells is the most probable cause 
for the increase in the number of IgM-secreting cells observed 
after BAFF treatment of splenocyte cultures. In mammals, there 
is some controversy regarding the effects of BAFF on antibody 
secretion. In mice, the administration of BAFF alone, increased 
serum IgM and IgA levels, but had no effect on IgG (59), again 
pointing to preferred BAFF actions outside the GC. On the other 
hand, transgenic mice overexpressing BAFF had increased IgG 
levels, while IgM levels were only slightly augmented (72). Finally, 
when BAFF was administered in combination with a Streptococcus 
pneumoniae vaccine, IgM, and IgG were only marginally affected, 
whereas BAFF markedly increased IgA production (51). In trout, 
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we have established that BAFF increases the secretion of IgM in 
the spleen in a Blimp-1-independent fashion, ruling out a role 
of BAFF as a B  cell differentiation factor. This increased IgM 
production seems to be a direct consequence of the increased 
survival of pre-existing IgM-secreting cells.
In conclusion, we have demonstrated that different teleost 
B cell populations respond to BAFF. Splenic IgM+ B cells, the main 
cell type producing BAFF in this tissue, are able to extend their 
survival and upregulate their MHC II surface levels in response to 
the cytokine. Splenic plasmablasts do not produce BAFF in physi-
ological conditions (data not shown) but also have an increased 
survival rate in response to the cytokine, which results in increased 
IgM secretion levels. Our results reveal an ancient mechanism 
through which BAFF regulates B cell function in teleost. To our 
knowledge, this is the first study that demonstrates this unique 
regulatory pathway on B  cells under physiological conditions. 
Thus, our findings unravel the ancient origin of this regulatory 
mechanism that reemerges in a variety of B cell disorders such as 
autoimmune diseases or B cell malignancies.
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